Is there a connection between China, Bill Gates, YouTube, and DNA collection?
Recent reports reveal that a Chinese company with connections to the Gates Foundation is involved in COVID-19 testing and poses a potential threat to American privacy, particularly the medical and health data of those who have been tested for COVID-19.
In late January, CBS’ 60 Minutes reported:
“60 Minutes has learned Chinese company BGI Group, the largest biotech firm in the world, offered to build COVID labs in at least six states, and U.S. intelligence officials issued warnings not to share health data with BGI.
The largest biotech firm in the world wasted no time in offering to build and run COVID testing labs in Washington, contacting its governor right after the first major COVID outbreak in the U.S. occurred there. The Chinese company, the BGI Group, made the same offer to at least five other states, including New York and California, 60 Minutes has learned. This, along with other COVID testing offers by BGI, so worried Bill Evanina, then the country’s top counterintelligence officer, that he authorized a rare public warning.”
“Foreign powers can collect, store and exploit biometric information from COVID tests” declared the notice. Evanina believes the Chinese are trying to collect Americans’ DNA to win a race to control the world’s biodata.”
Evanina said a foreign entity could learn about a person’s current or future medical conditions by studying their DNA and using this information to gain a monopoly over necessary drugs and treatments.
BGI Group declined to be interviewed by 60 Minutes and said the idea that Americans genomic data has been compromised by BGI is “groundless”.
Concerns around BGI also arose in late January when Reuters reported that more than 40 publicly available documents and research papers show BGI’s links to the People’s Liberation Army (PLA). Reuters said the research dealt with topics as varied as mass testing for respiratory pathogens to brain science.
Read more: Bill Gates, China, 23andMe, and Your DNA
